ArticleBMC bioinformatics2026
Multivariate GWAS framework for family trios with parental phenotypes to control dynastic effects.
Article in BMC bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundEffect size estimates in genome-wide association studies (GWAS) and Mendelian randomization (MR) based on unrelated individuals are often confounded by dynastic effects (DE). Existing family-trio-based methods can mitigate this bias, but they typically discard parental phenotypes and cannot jointly model multiple correlated traits. We propose FT-SEM, a multivariate GWAS framework that uses structural equation modeling for family trio data, with the aim of integrating genotypes and phenotypes from parents and offspring across multiple traits to estimate direct genetic effects on a shared latent factor.
resultsSimulations demonstrated that FT-SEM yields unbiased effect estimates with well-controlled type I error, while improving statistical power over conventional trio-based models by incorporating parental phenotypic information. In a genome-wide scan of 778 UK Biobank family trios, no locus reached genome-wide significance, but the FT-SEM-derived family-corrected summary statistics for a latent obesity factor provided an unbiased outcome base for downstream MR. Two-sample MR analyses revealed that the apparent association between systolic blood pressure and obesity was substantially attenuated after accounting for familial confounding, suggesting that it may be spurious. In contrast, the effect of high-density lipoprotein cholesterol on obesity remained directionally consistent and robust, supporting a genuine causal relationship.
conclusionsFT-SEM provides a rigorous and efficient multivariate framework that eliminates dynastic bias while maximizing the utility of family-trio data. The resulting summary statistics can be seamlessly integrated into two-sample MR analyses, highlighting the necessity of family-trio-informed multivariate modeling for guarding against spurious causal claims in complex trait genetics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.